SGLT2 inhibitor outcome trials: Future opportunities
Dr David Fitchett
10' education - Sep. 27, 2015 - London - Dr David Fitchet, Toronto, CanadaVideo navigation menu
Glycemic control: unmet needs 00:01
SGLT2 inhibitors 01:11
The EMPA-REG OUTCOME trial 03:20
Conclusions 07:58
Educational information
This has no CME
The content is aimed for medical professionals. To view this item member registration is needed. Register for free to get unlimited access to our educational resources.
Share this page with your colleagues and friends: